We are live on ! Find out more
ACM

Athyrium Capital Management Portfolio holdings

AUM $8.69M
1-Year Est. Return 34.58%
This Fund
S&P 500
This Quarter Est. Return
-4.37%
1 Year Est. Return
-34.58%
3 Year Est. Return
-25.1%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$238M
AUM Growth
-$29.1M
Cap. Flow
-$117M
Cap. Flow %
-49.35%
Top 10 Hldgs %
98.62%
Holding
11
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
+$3.65M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 47.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMYT
1
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$64.7M 27.18%
8,857,268
– –
RVLP
2
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$16.4M 6.87%
14,600,444
– –
CMAX
3
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$16.3M 6.85%
148,907
– –
PBYI icon
4
Puma Biotechnology
PBYI
$398M
$7.58M 3.19%
1,792,114
– –
BIOR
5
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$5.58M 2.34%
169,448
+50,025
+42% +$3.65M
SCTL
6
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$3.28M 1.38%
2,202,420
– –

Similar funds

BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
KIM
Kaizen Investment Management Singapore $6.23M AUM
RJTCONH
Raymond James Trust Company of New Hampshire Portsmouth, New Hampshire $12.1M AUM 28.84% 1-Year Est. Return
HSC
Harbor Spring Capital New York $12.3M AUM
HVM
Harvest Volatility Management Norwalk, Connecticut $4.39M AUM 13.08% 1-Year Est. Return

Athyrium Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Athyrium Capital Management held 11 positions worth $238M, down 11% from $267M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Athyrium Capital Management withdrew a net $117M in Q4 2022.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 55% a quarter earlier.

Against the trend, Athyrium Capital Management added an estimated $3.65M to Biora Therapeutics, Inc. Common Stock.

  • Athyrium Capital Management added most to Biora Therapeutics, Inc. Common Stock in Q4 2022, an estimated $3.65M increase.
  • Athyrium Capital Management's ten largest holdings make up 99% of its $238M portfolio in Q4 2022.
  • Athyrium Capital Management opened 0 new positions and closed 0 in Q4 2022.
  • Athyrium Capital Management's portfolio value fell 11% quarter-over-quarter to $238M.

Based on Athyrium Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.